Alnylam Pharmaceuticals revenue
Alnylam Pharmaceuticals (ALNY) reported revenue of $3.71 B for fiscal year 2025, +65.2% compared with the year before. Over the last 12 months revenue was $5.01 B.
Revenue 2025$3.71 B
Change+65.2%
World rank#755
Market cap$20.01 B
Revenue by year
By year
| Year | Value | Change |
|---|---|---|
| 2025 | $3.71 B | +65.2% |
| 2024 | $2.25 B | +23.0% |
| 2023 | $1.83 B | +76.2% |
| 2022 | $1.04 B | — |
Data: company filings via Yahoo Finance, updated 2026-11-19. Not investment advice.